logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2011 or most recent year available

Part (v) New stimulants (other than cocaine) inpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n)Frequency unknown
Belgium12.52512.55082
Bulgaria::33.366.730
Czech Republic12.515.943.428.270530
Denmark::66.733.330
Germany::::::
Estonia::::::
Ireland140.0:30.030.0100
Greece::100.0:10
Spain::::::
France::::00
Italy::::::
Cyprus50.0:50.0:20
Latvia::::::
Lithuania::::::
Luxembourg::::::
Hungary:26.315.857.9191
Malta::::::
Netherlands9.15.523.661.85526
Austria71.47.1:21.4140
Poland215.11.952.830.253:
Portugal::::::
Romania:33.333.333.336
Slovenia::::::
Slovakia4.416.544.035.2915
Finland30.010.030.030.0100
Sweden126.88.226.838.11948
United Kingdom3::::::
Croatia:::::4
Turkey:11.111.177.891
Norway::::::
Total14.913.438.633.0118083
 

Notes:

: Indicates data are not available

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013